G protein–coupled receptor 41 deficiency exacerbates dextran sulfate sodium-induced colitis and is associated with altered gut microbiota composition
Inflammatory bowel disease comprises chronic, relapsing inflammatory disorders of the gastrointestinal tract. G protein-coupled receptor 41 (GPR41), a receptor for short-chain fatty acids, has been implicated in intestinal immune regulation, but its contribution to colitis and the underlying mechanisms remain incompletely understood. Here, we investigated the susceptibility of GPR41-deficient ( Gpr41 -/- ) mice to dextran sulfate sodium (DSS)-induced colitis. Gpr41 -/- mice exhibited more severe colitis, including greater body weight loss and greater colon shortening, than littermate controls. Under antibiotic treatment, no statistically significant differences in colitis severity were detected between Gpr41 -/- mice and littermate controls. Furthermore, 16S rRNA gene amplicon analysis revealed differences in gut microbial diversity and composition between Gpr41 -/- mice and littermate controls at steady state, with compositional differences also observed after DSS treatment. GPR41 deficiency was also associated with reduced fecal levels of the iron-binding proteins lipocalin-2 (LCN2) and lactoferrin (LTF) at steady state. Prophylactic administration of recombinant LCN2 was associated with numerically lower colitis severity in Gpr41 -/- mice, although the differences were not statistically significant. Together, these findings support a protective role for GPR41 in DSS-induced colitis and identify associated changes in iron-binding protein levels and gut microbiota composition.
Authors
- Akira Suto (ORCID: https://orcid.org/0000-0002-2593-565X)
- Kotaro Suzuki (ORCID: https://orcid.org/0000-0002-4692-2970)
- Arifumi Iwata (ORCID: https://orcid.org/0000-0002-8771-481X)
- Ikuo Kimura (ORCID: https://orcid.org/0000-0001-8778-145X)
- Shigeru Tanaka (ORCID: https://orcid.org/0000-0002-8466-110X)
- Atsuko Tomikawa
- Takahiro Kageyama (ORCID: https://orcid.org/0000-0002-9450-5848)
- Kazuyuki Meguro
- Takashi Ito
- Hiroshi Nakajima
Institutions
- Chiba University (JP)
- Kyoto University (JP)
- University of California San Diego (US)
- Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University (JP)
- Tokyo University of Agriculture and Technology (JP)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1038/s41598-026-80080-5
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Chiba University
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Moonshot Research and Development Program